Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.
23/01/2008
Gomez-Reino JJ, Carmona L, Descalzo MA, Biobadaser Group.
Descargar documento
Arthritis Rheum, 2007;57(5):756-61